-

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Catalent; Is $63.50 a Fair Price?

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Catalent (NYSE:CTLT) breached their fiduciary duties in connection with the proposed sale of the Company to Novo Holdings.

You can click on the following link to join this investigation:

Click Here to Join the Investigation

On February 5, 2024, Catalent announced that it had entered a deal to merge with Novo Holdings. Under the terms of the deal, Catalent shareholders will receive $63.50 per share in an all-cash offer.

The investigation concerns whether the Catalent board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Catalent shares of common stock. Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts' projections for future earnings growth. Last March Catalent shares traded as high as $74.49.

If you are a shareholder of Catalent and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Johnson Fistel, LLP

NYSE:CTLT

Release Versions

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, LLP

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches at Lee Enterprises, Inc.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duty by the Board of Directors of Lee Enterprises, Inc. (NASDAQ: LEE).If you own Lee Enterprises shares, please consider joining our investigation. To participate or learn more, you can click or copy and paste the following link:https://www.johnsonfistel.com/investigations/lee-enterprises-inc/Shareholders seeking more information may also contact lead analyst Jim Baker (jimb@johnsonfi...

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Select Medical Holdings Corporation (NYSE: SEM) breached their fiduciary duties in connection with the proposed sale of the company to a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe.If you own Select Medical shares and believe this proposed transaction undervalues your investment, please consider joining o...

Marriott Vacations Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Marriott Vacations Worldwide Corporation (NYSE: VAC). The investigation focuses on Marriott Vacations’ executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Marriott Vacations securities? If you purchased Marriott Vacations securities and suffered losses on your investment, join our investigation now: Click here to join the inv...
Back to Newsroom